Physician profile
Brian A Clements
NPI 1265540009
$9,945.04
in general payments reported to CMS, 2019-2025
55 companies · $1,558 in 2025
The $1,558 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,041 · 2020: $1,203 · 2021: $1,654 · 2022: $1,433 · 2023: $1,379 · 2024: $1,677 · 2025: $1,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,614.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,554.52 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $799.84 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $746.70 | 2019-2025 | Evenity, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $641.08 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $620.58 | 2019-2022 | |
| Astellas Pharma US INC | $542.73 | 2020-2025 | Veozah |
| Lilly USA, LLC | $495.15 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $483.29 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $433.36 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $338.79 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $326.57 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $272.65 | 2021-2025 | |
| Mylan Specialty L.P. | $271.13 | 2019-2024 | Yupelri |
| Glaxosmithkline, LLC. | $153.44 | 2019-2025 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $153.42 | 2019-2023 | Verquvo, Belsomra, Steglatro |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Clements listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.